The Heart Attack Diagnostics Market is being driven by increasing cardiovascular disease prevalence, an aging population, technological innovation, and growing demand for rapid diagnostic procedures.

High-sensitivity cardiac troponin assays have become an important component of acute myocardial infarction diagnosis. Blood tests held a 43.5% market share in 2025, reflecting the widespread use of high-sensitivity troponin protocols.

Artificial intelligence is another major market trend. AI-powered ECG systems can assist healthcare professionals in identifying cardiac abnormalities and prioritizing high-risk patients. Wearable and AI-driven ECG systems are projected to expand at a CAGR of 13.8% through 2035.

Remote monitoring and tele-cardiology are also creating new opportunities. Home-based and tele-cardiology applications are projected to grow at a 15.2% CAGR, making them one of the fastest-growing end-user channels.

The increasing use of cloud-connected diagnostic platforms, portable ECG devices, point-of-care testing, and advanced cardiac imaging is expected to further transform diagnostic workflows over the coming years.